细胞生物学
染色质
内体
微核试验
胞浆
ESCRT公司
生物
活性氧
线粒体
化学
生物化学
DNA
细胞内
有机化学
毒性
酶
作者
Melody Di Bona,Yanyang Chen,Albert S. Agustinus,Alice Mazzagatti,Mercedes A. Duran Paez,Matthew Deyell,Daniel Bronder,James H. Hickling,Christy Hong,Lorenzo Scipioni,G Tedeschi,Sara Martin,Jun Li,Aušrinė Ruzgaitė,Nadeem Riaz,Parin Shah,Edridge D’Souza,D. Zack Brodtman,Simone Sidoli,Bill H. Diplas
出处
期刊:Science
[American Association for the Advancement of Science]
日期:2024-08-29
卷期号:385 (6712)
被引量:18
标识
DOI:10.1126/science.adj8691
摘要
Chromosome-containing micronuclei are a hallmark of aggressive cancers. Micronuclei frequently undergo irreversible collapse, exposing their enclosed chromatin to the cytosol. Micronuclear rupture catalyzes chromosomal rearrangements, epigenetic abnormalities, and inflammation, yet mechanisms safeguarding micronuclear integrity are poorly understood. In this study, we found that mitochondria-derived reactive oxygen species (ROS) disrupt micronuclei by promoting a noncanonical function of charged multivesicular body protein 7 (CHMP7), a scaffolding protein for the membrane repair complex known as endosomal sorting complex required for transport III (ESCRT-III). ROS retained CHMP7 in micronuclei while disrupting its interaction with other ESCRT-III components. ROS-induced cysteine oxidation stimulated CHMP7 oligomerization and binding to the nuclear membrane protein LEMD2, disrupting micronuclear envelopes. Furthermore, this ROS-CHMP7 pathological axis engendered chromosome shattering known to result from micronuclear rupture. It also mediated micronuclear disintegrity under hypoxic conditions, linking tumor hypoxia with downstream processes driving cancer progression.
科研通智能强力驱动
Strongly Powered by AbleSci AI